Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.33225 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.21941 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.29548 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.97494 | 81 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.18262 | 76 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.23325 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.21595 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.21468 | 77 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.0338 | 75 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.21155 | 76 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.20224 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.11564 | 76 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.21303 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.20745 | 77 |